Showing results (1111-1120 of 1,164) with videos related to
Sort By:
Pageof 117
Vaccine|November 2, 2025
Preventive effect of vaccination on long COVID in adolescents with SARS-CoV-2 infectionTanayott Thaweethai, Rachel S Gross, Deepti B Pant, et al.Academic Pediatrics|April 5, 2026
School Difficulties and Long COVID in Children and AdolescentsHarrison T Reeder, Lawrence C Kleinman, Melissa S Stockwell, et al.Journal of Developmental and Behavioral Pediatrics : JDBP|April 15, 2026
Parental Cognitive Stimulation of Young Children Before and After the Onset of the COVID-19 PandemicAnne Martin, Elizabeth B Miller, Danruo Zhong, et al.Journal of Medicinal Chemistry|March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituentsDeborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.Journal of the American Society of Nephrology : JASN|June 7, 2015
Urine Metabolite Profiles Predictive of Human Kidney Allograft StatusKarsten Suhre, Joseph E Schwartz, Vijay K Sharma, et al.Autophagy|January 25, 2017
Dietary spermidine for lowering high blood pressureTobias Eisenberg, Mahmoud Abdellatif, Andreas Zimmermann, et al.Journal of Medicinal Chemistry|October 25, 2008
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's diseaseXiaohu Zhang, John E Tellew, Zhiyong Luo, et al.Molecular Psychiatry|March 24, 2010
Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigreeK-P Lesch, S Selch, T J Renner, et al.European Heart Journal|April 27, 2007
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging studyVladimir Dzavík, Gad Cotter, Harmony R Reynolds, et al.Blood Advances|January 9, 2026
Neutrophil CD14 is a Driver and a Therapeutic Target for Deep Vein ThrombosisNilesh Pandey, Harpreet Kaur, Raktim Mitra, et al.Pageof 117